BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1988 related articles for article (PubMed ID: 32539942)

  • 1. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
    Whisenant JG; Trama A; Torri V; De Toma A; Viscardi G; Cortellini A; Michielin O; Barlesi F; Dingemans AC; Van Meerbeeck J; Pancaldi V; Soo RA; Leighl NB; Peters S; Wakelee H; Garassino MC; Horn L
    Cancer Cell; 2020 Jun; 37(6):742-745. PubMed ID: 32425702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
    Kuderer NM; Choueiri TK; Shah DP; Shyr Y; Rubinstein SM; Rivera DR; Shete S; Hsu CY; Desai A; de Lima Lopes G; Grivas P; Painter CA; Peters S; Thompson MA; Bakouny Z; Batist G; Bekaii-Saab T; Bilen MA; Bouganim N; Larroya MB; Castellano D; Del Prete SA; Doroshow DB; Egan PC; Elkrief A; Farmakiotis D; Flora D; Galsky MD; Glover MJ; Griffiths EA; Gulati AP; Gupta S; Hafez N; Halfdanarson TR; Hawley JE; Hsu E; Kasi A; Khaki AR; Lemmon CA; Lewis C; Logan B; Masters T; McKay RR; Mesa RA; Morgans AK; Mulcahy MF; Panagiotou OA; Peddi P; Pennell NA; Reynolds K; Rosen LR; Rosovsky R; Salazar M; Schmidt A; Shah SA; Shaya JA; Steinharter J; Stockerl-Goldstein KE; Subbiah S; Vinh DC; Wehbe FH; Weissmann LB; Wu JT; Wulff-Burchfield E; Xie Z; Yeh A; Yu PP; Zhou AY; Zubiri L; Mishra S; Lyman GH; Rini BI; Warner JL;
    Lancet; 2020 Jun; 395(10241):1907-1918. PubMed ID: 32473681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.
    Götzinger F; Santiago-García B; Noguera-Julián A; Lanaspa M; Lancella L; Calò Carducci FI; Gabrovska N; Velizarova S; Prunk P; Osterman V; Krivec U; Lo Vecchio A; Shingadia D; Soriano-Arandes A; Melendo S; Lanari M; Pierantoni L; Wagner N; L'Huillier AG; Heininger U; Ritz N; Bandi S; Krajcar N; Roglić S; Santos M; Christiaens C; Creuven M; Buonsenso D; Welch SB; Bogyi M; Brinkmann F; Tebruegge M;
    Lancet Child Adolesc Health; 2020 Sep; 4(9):653-661. PubMed ID: 32593339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.
    Tian J; Yuan X; Xiao J; Zhong Q; Yang C; Liu B; Cai Y; Lu Z; Wang J; Wang Y; Liu S; Cheng B; Wang J; Zhang M; Wang L; Niu S; Yao Z; Deng X; Zhou F; Wei W; Li Q; Chen X; Chen W; Yang Q; Wu S; Fan J; Shu B; Hu Z; Wang S; Yang XP; Liu W; Miao X; Wang Z
    Lancet Oncol; 2020 Jul; 21(7):893-903. PubMed ID: 32479790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
    Trama A; Proto C; Whisenant JG; Torri V; Cortellini A; Michielin O; Barlesi F; Dingemans AC; Van Meerbeeck J; Pancaldi V; Mazieres J; Soo RA; Leighl NB; Peters S; Wakelee H; Horn L; Hellmann M; Wong SK; Garassino MC; Baena J
    Cancer Cell; 2020 Nov; 38(5):602-604. PubMed ID: 33091381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
    Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
    BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
    Lee LY; Cazier JB; Angelis V; Arnold R; Bisht V; Campton NA; Chackathayil J; Cheng VW; Curley HM; Fittall MW; Freeman-Mills L; Gennatas S; Goel A; Hartley S; Hughes DJ; Kerr D; Lee AJ; Lee RJ; McGrath SE; Middleton CP; Murugaesu N; Newsom-Davis T; Okines AF; Olsson-Brown AC; Palles C; Pan Y; Pettengell R; Powles T; Protheroe EA; Purshouse K; Sharma-Oates A; Sivakumar S; Smith AJ; Starkey T; Turnbull CD; Várnai C; Yousaf N; ; Kerr R; Middleton G
    Lancet; 2020 Jun; 395(10241):1919-1926. PubMed ID: 32473682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
    Cummings MJ; Baldwin MR; Abrams D; Jacobson SD; Meyer BJ; Balough EM; Aaron JG; Claassen J; Rabbani LE; Hastie J; Hochman BR; Salazar-Schicchi J; Yip NH; Brodie D; O'Donnell MR
    Lancet; 2020 Jun; 395(10239):1763-1770. PubMed ID: 32442528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
    García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
    J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital.
    Turcotte JJ; Meisenberg BR; MacDonald JH; Menon N; Fowler MB; West M; Rhule J; Qureshi SS; MacDonald EB
    PLoS One; 2020; 15(8):e0237558. PubMed ID: 32785285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
    Vuagnat P; Frelaut M; Ramtohul T; Basse C; Diakite S; Noret A; Bellesoeur A; Servois V; Hequet D; Laas E; Kirova Y; Cabel L; Pierga JY; ; Bozec L; Paoletti X; Cottu P; Bidard FC
    Breast Cancer Res; 2020 May; 22(1):55. PubMed ID: 32460829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
    Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
    Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.
    Angelis V; Tippu Z; Joshi K; Reis S; Gronthoud F; Fribbens C; Okines A; Stanway S; Cottier E; McGrath S; Watkins D; Noble J; Bhosle J; Gerlinger M; Hamid I; Soliman H; Nenclares P; Jones R; Harrington K; Gennatas S
    Eur J Cancer; 2020 Sep; 136():99-106. PubMed ID: 32659475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
    Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
    Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
    Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
    Lee LYW; Cazier JB; Starkey T; Briggs SEW; Arnold R; Bisht V; Booth S; Campton NA; Cheng VWT; Collins G; Curley HM; Earwaker P; Fittall MW; Gennatas S; Goel A; Hartley S; Hughes DJ; Kerr D; Lee AJX; Lee RJ; Lee SM; Mckenzie H; Middleton CP; Murugaesu N; Newsom-Davis T; Olsson-Brown AC; Palles C; Powles T; Protheroe EA; Purshouse K; Sharma-Oates A; Sivakumar S; Smith AJ; Topping O; Turnbull CD; Várnai C; Briggs ADM; Middleton G; Kerr R;
    Lancet Oncol; 2020 Oct; 21(10):1309-1316. PubMed ID: 32853557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 100.